Brain MR Imaging Findings of Cardiac-Type Fabry Disease with an IVS4+919G>A Mutation

References

1. 1.↵
   1. Scriver CR

   2. Desnick RJ,
   3. Ioannou YA,
   4. Eng CM

   . α-galactosidase A deficiency: Fabry disease. In: Scriver CR, ed. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2001:3733–74
2. 2.↵
   2. Reisin RC,
   3. Romero C,
   4. Marchesoni C, et al

   . Brain MRI findings in patients with Fabry disease. J Neurol Scis 2011;305:41–44 doi:10.1016/j.jns.2011.03.020 pmid:21463870

   CrossRefPubMed
3. 3.↵
   2. Chong KW,
   3. Lu YH,
   4. Hsu JH, et al

   . High incidence of cardiac variant of Fabry disease in Taiwanese revealed by newborn screening. In: Proceedings of the Taiwan Human Genetics Society Autumn Symposium, Hualien, Taiwan. October 4–5, 2008
4. 4.↵
   2. Lin HY,
   3. Chong KW,
   4. Hsu JH, et al

   . High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population. Circ Cardiovasc Genet 2009;2:450–56 doi:10.1161/CIRCGENETICS.109.862920 pmid:20031620

   Abstract/FREE Full Text
5. 5.↵
   2. Chien YH,
   3. Lee NC,
   4. Chiang SC, et al

   . Fabry disease: incidence of the common later-onset α-galactosidase A IVS4+919G→A mutation in Taiwanese newborns: superiority of DNA-based to enzyme-based newborn screening for common mutations. Mol Med 2012;18:780–84 doi:10.2119/molmed.2012.00002 pmid:22437327

   CrossRefPubMed
6. 6.↵
   2. Ishii S,
   3. Nakao S,
   4. Minamikawa-Tachino R, et al

   . Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype. Am J Hum Genet 2002;70:994–1002 doi:10.1086/339431 pmid:11828341

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Takanashi Ji,
   3. Barkovich AJ,
   4. Dillon WP, et al

   . T1 hyperintensity in the pulvinar: key imaging feature for diagnosis of Fabry disease. AJNR Am J Neuroradiol 2003;24:916–21 pmid:12748094

   Abstract/FREE Full Text
8. 8.↵
   2. Fazekas F,
   3. Chawluk JB,
   4. Alavi A, et al

   . MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351–66 doi:10.2214/ajr.149.2.351 pmid:3496763

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Smoker WR,
   3. Corbett JJ,
   4. Gentry LR, et al

   . High-resolution computed tomography of the basilar artery, 2: vertebrobasilar dolichoectasia—clinical-pathologic correlation and review. AJNR Am J Neuroradiol 1986;7:61–72 pmid:3082145

   Abstract/FREE Full Text
10. 10.↵
    2. Tsai A,
    3. Huang CC,
    4. Yang AC, et al

    . Association of BACE1 gene polymorphism with cerebellar volume but not cognitive function in normal individuals. Dement Geriatr Cogn Dis Extra 2012;2:632–37 doi:10.1159/000345980 pmid:23341828

    CrossRefPubMed
11. 11.↵
    2. Ashburner J

    . A fast diffeomorphic image registration algorithm. Neuroimage 2007;38:95–113 doi:10.1016/j.neuroimage.2007.07.007 pmid:17761438

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Schmidt P,
    3. Gaser C,
    4. Arsic M, et al

    . An automated tool for detection of FLAIR-hyperintense white-matter lesions in multiple sclerosis. Neuroimage 2012;59:3774–83 doi:10.1016/j.neuroimage.2011.11.032 pmid:22119648

    CrossRefPubMed
13. 13.↵
    2. Ashburner J,
    3. Friston KJ

    . Unified segmentation. Neuroimage 2005;26:839–51 doi:10.1016/j.neuroimage.2005.02.018 pmid:15955494

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Sims K,
    3. Politei J,
    4. Banikazemi M, et al

    . Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry registry. Stroke 2009;40:788–94 doi:10.1161/STROKEAHA.108.526293 pmid:19150871

    Abstract/FREE Full Text
15. 15.↵
    2. Buechner S,
    3. Moretti M,
    4. Burlina AP, et al

    . Central nervous system involvement in Anderson-Fabry disease: a clinical and MRI retrospective study. J Neurol Neurosurg Psychiatry 2008;79:1249–54 doi:10.1136/jnnp.2008.143693 pmid:18535022

    Abstract/FREE Full Text
16. 16.↵
    2. Rolfs A,
    3. Böttcher T,
    4. Zschiesche M, et al

    . Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 2005;366:1794–96 doi:10.1016/S0140-6736(05)67635-0 pmid:16298216

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Fellgiebel A,
    3. Müller MJ,
    4. Ginsberg L

    . CNS manifestations of Fabry's disease. Lancet Neurol 2006;5:791–95 doi:10.1016/S1474-4422(06)70548-8 pmid:16914407

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Kolodny E,
    3. Fellgiebel A,
    4. Hilz MJ, et al

    . Cerebrovascular involvement in Fabry disease: current status of knowledge. Stroke 2015;46:302–13 doi:10.1161/STROKEAHA.114.006283 pmid:25492902

    FREE Full Text
19. 19.↵
    2. deVeber GA,
    3. Schwarting GA,
    4. Kolodny EH, et al

    . Fabry disease: immunocytochemical characterization of neuronal involvement. Ann Neurol 1992;31:409–15 doi:10.1002/ana.410310410 pmid:1375013

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Prins ND,
    3. van Straaten EC,
    4. van Dijk EJ, et al

    . Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics. Neurology 2004;62:1533–39 doi:10.1212/01.WNL.0000123264.40498.B6

    Abstract/FREE Full Text
21. 21.↵
    2. Politei J,
    3. Schenone AB,
    4. Burlina A, et al

    . Vertebrobasilar dolichoectasia in Fabry disease: the earliest marker of neurovascular involvement? JIEMS 2014;2:2326409814541246 doi:10.1177/2326409814541246

    Abstract/FREE Full Text
22. 22.↵
    2. Fellgiebel A,
    3. Keller I,
    4. Marin D, et al

    . Diagnostic utility of different MRI and MR angiography measures in Fabry disease. Neurology 2009;72:63–68 doi:10.1212/01.wnl.0000338566.54190.8a pmid:19122032

    Abstract/FREE Full Text
23. 23.↵
    2. Fellgiebel A,
    3. Keller I,
    4. Martus P, et al

    . Basilar artery diameter is a potential screening tool for Fabry disease in young stroke patients. Cerebrovasc Dis 2011;31:294–99 doi:10.1159/000322558 pmid:21196729

    CrossRefPubMed
24. 24.↵
    2. Uçeyler N,
    3. Homola GA,
    4. Guerrero González H, et al

    . Increased arterial diameters in the posterior cerebral circulation in men with Fabry disease. PLoS One 2014;9:e87054 doi:10.1371/journal.pone.0087054 pmid:24475221

    CrossRefPubMed
25. 25.↵
    2. Moore DF,
    3. Ye F,
    4. Schiffmann R, et al

    . Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease. AJNR Am J Neuroradiol 2003;24:1096–101 pmid:12812932

    Abstract/FREE Full Text